维普期刊资源整合服务平台（V6.5）

45篇 您的检索式：作者名="Oethinger M"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	GyrA mutations in high-level fluoroquinolone-resistant clinical isolates of Escherichia coli显示文摘	Conrad S Oethinger M	1996	Journal of Antimicrobial Chemotherapy1996，38，3：	1
2	Ineffectiveness of topoisomerase mutations in mediating clinically significant fluoroquinolone resistance in Escherichia coli in the absence of the AcrAB ettlux pump显示文摘	Oethinger M Kern W V Jellen-Ritter A S	2000	Antimicrob Agents Chemother2000，44，1：	1
3	Nontarget gene mutations in the development of fluoroquinolone resistance in Escherichia coli显示文摘	Kern MV Oethinger M Jellen-Ritter AS		0，，：	1
4	Over expression of marA, soxS, or aerAB produces resistance to trielosan in laboratory and clinical strains of Escherichia coli显示文摘	McMun'y LM Oethinger M Levy SB	1998	FEMS Microbiol Lett1998，166，2：	1
5	Ineffectiveness of topoisomerasemutations in mediating clinically significant fluoroquinolone resistance in Escherichia coli in the absence of the AcrAB efflux pump显示文摘	M Oethinger WV Kern AS Jellen-Ritter	2000	Antimicrob Agents Chemother2000，44，1：	1
6	Triclosan targets lipid synthesis显示文摘	McMurry LM Oethinger M Levy SB	1998	Nature1998，394，6693：	1
7	GyrA mutations in high-level fluoroquinolone resistant clinical isoltates of Escherichia coli 显示文摘	Conrad S Oethinger M Kaifel K etal	1996	Antimicrob Agents Chemother1996，38，4：	1
8	Overexpression of the marA or soxS regulatory gene in clinical topoiso- merase mutants of Escherichia coli 显示文摘	Oethinger M Podglajen I Kern WV	1998	Antimicrob Agents Chemother1998，42，8：	1
9	Ttriclosan targets lipid synthesis显示文摘	McMurray L M Oethinger M Levy S B	1998	Nature1998，394，：	1
10	Ineffectiveness of topoisomerase mutations in mediating clinically significant fluoroquinolone resistance in Escherichia coli in the absence of the AcrAB efflux pump显示文摘	Oethinger M Kern A S Jellen-Ritter L	2000	Antimicrobial Agents and Chemotherapy2000，44，：	1
11	Overexpression of marA,soxS,or acrAB produces resistance to triclosan in laboratory and clinical strains of Escherichia coli显示文摘	McMurry LM Oethinger M Levy SB	1998	FEMS Microbiol Lett1998，166，：	1
12	Non-target gene mutations in the development of fluoroquinolone resistance in Escherichia coli 显示文摘	Kern WV Oethinger M Jellen-Ritter AS	2000	Antimicrob Agents Chemother2000，44，4：	1
13	Triclosan tar- gets lipid synthesis 显示文摘	McMurry L M Oethinger M Levy S B	1998	Nature1998，394，6693：	1
14	Overexpression of the MarA or SoxS regulatory gene in clinical topoisomerase mutants of Escherichia coli 显示文摘	Oethinger M Podglajen I Kern WV	1998	Antimicrob Agents Chemother1998，42，8：	1
15	Ineffectiveness of topoisomerase mutations in mediating clinically significant fluoroquinolone resistance in Escherichia coli in the absence of the AcrAB efflux pump显示文摘	Oethinger M Kern WV Jellen-Ritter AS	2000	Antimicrob Agents Chemother2000，44，1：	1
16	Overexpression of marA, soxS, or acrAB produces resistance to tri- closan in laboratory and clinical strains of Eseherichia eoli 显示文摘	Mcmurry L M Oethinger M Levy S B	1998	FEMS Microbiology Letters1998，166，2：	1
17	Triclosan targets lipid synthesis 显示文摘	McMurry LM Oethinger M Levy SB	1998	Nature1998，394，6693：	1
18	Nontarget gene mutations in the development of fluoroquinolone-resistance in Escherichia coli显示文摘	Kern M V Oethinger M Jellen-Ritter A S	2000	Antimicrob Agents Chemother2000，44，：	1
19	Efficiency of the ortho VITROS assay for detection of hepatitis C virus - specific antibodies increased by elimination of supplemental testing of samples with very low sample -to -cutoff ratios显示文摘	Oethinger M Mayo DR Falcone J	2005	J Clin Microbiol2005，43，5：	1
20	Unsuitable distinction between viable and dead staphylococcus aureus and staphylococcus epidermidis by ethidium bromide monoazide 显示文摘	Kobayashi H Oethinger M Tuohy M J	2009	Lett Appl Microbiol2009，48，5：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示